Navigation Links
ChemAxon Announces New Version of chemicalize.org for Tablet PCs
Date:8/14/2012

BUDAPEST, Hungary, August 14, 2012 /PRNewswire/ --

ChemAxon, a leader in providing chemistry software for the biotechnology and pharmaceutical industries, announces that its free, open access, web-based chemistry search and extraction service, chemicalize.org, is now supported on touchscreen tablet PCs including Apple iPad and Android devices. This new version provides users with high resolution chemically-intelligent web search and extraction on the move.

Powered by ChemAxon technology and used by scientists worldwide, chemicalize.org identifies chemical names (SMILES, InChI, traditional and IUPAC names) on websites, in text and PDF files, converting them to 2D structures. Researchers can also calculate and explore a range of structure-based properties, search by structure in the ever expanding chemicalize.org knowledge-base, and search the internet to find all websites citing a particular chemical structure.  

The new chemicalize.org features:

  • higher resolution images for "Retina"-type displays found in the iPhone 4, iPad and new Android devices, including the Samsung Galaxy Nexus and SIII,
  • the ability to focus on the most relevant information/properties when accessing from a mobile device,
  • Home Screen shortcuts for rapid access, and
  • user interface controls and performance optimized for tablets and smartphones.

To try for yourself visit http://www.chemicalize.org

To discover more about how ChemAxon's leading edge cross platform solutions power modern cheminformatics and chemical communication, please visit http://www.chemaxon.com

About ChemAxon

ChemAxon is a leader in providing cheminformatics software development platforms and desktop applications for the biotechnology, pharmaceutical and agrochemical industries. With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions and programming interfaces to power modern cheminformatics and chemical communication. The company is privately owned with European headquarters in Budapest and sales and support offices in Europe, Japan and North America.

The ChemAxon logo is a trademark of ChemAxon Ltd. All rights reserved. All other trademarks mentioned in this document are the property of their respective owners.


'/>"/>
SOURCE ChemAxon
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Naturs Design Announces the Dreams With Hope Tour, a Nationwide Sleep Awareness Campaign
2. ADVENTRX Announces Appointment Of Chief Medical Officer
3. FDAnews Announces Medical Device Mobile Apps Virtual Conference
4. Dehaier Medical Announces 2012 Second Quarter and Six Month Financial Results
5. Isis Pharmaceuticals Announces Redemption Of 2 5/8% Convertible Subordinated Notes Due 2027
6. WuXi PharmaTech Announces Second-Quarter 2012 Results
7. Varian Medical Systems CEO Timothy E. Guertin Announces Plans to Retire; Board of Directors Names Dow R. Wilson as Successor
8. Comprehensive Care Corporation Announces Profitable Six Month Financial Results
9. Tactical Medical Packs Announces New Disaster Medical Packs Equipping First Responders for Mass Casualty Incidents
10. Echo Therapeutics Announces Second Quarter 2012 Financial Results
11. Bacterin International Announces Second Quarter and Six Months 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , Jan. 18, 2017  Tarix Orphan LLC ... has granted a Rare Pediatric Disease (RPD) designation for ... Recessive Dystrophic Epidermolysis Bullosa (RDEB), a rare genetic skin ... and treatment is limited to supportive care. ... Orphan Drug Designation previously granted by the FDA in ...
(Date:1/18/2017)... 2017  Astellas Pharma Inc. (President and CEO: ... its participation in Access Accelerated, a global, multi-stakeholder ... prevention, diagnostics and treatment in low-income and lower-middle ... companies and in collaboration with the World Bank ... (UICC), Astellas will work towards the United Nations ...
(Date:1/17/2017)... DUBLIN , Jan 17, 2017 Research ... Pancreas Devices System Market 2016-2020" report to their offering. ... The global artificial ... during the period 2016-2020. Global Artificial Pancreas Devices System ... with inputs from industry experts. The report covers the market landscape ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... January 18, 2017 , ... At Hallmark Nameplate, their commitment ... they have achieved certification to ISO 13485. This certification is another way they are ... date products and services that they need. , The ISO 13485 Certification is a ...
(Date:1/18/2017)... ... 2017 , ... The Hear the World Foundation, a Sonova ... of cochlear implants. In February 2017, the first three children with profound hearing ... leading an independent life. This engagement builds on the support the Hear the ...
(Date:1/17/2017)... ... January 17, 2017 , ... January is National Stalking Awareness Month (NSAM), now ... in the corners and commit the crime of stalking, a very real danger to many ... often overlooked factor in stalking and other crimes. , “Stalking: know it. Name it. Stop ...
(Date:1/17/2017)... ... January 17, 2017 , ... For breast cancer clinicians and ... or those who desire a more intimate review and analysis of its highlights, a ... to Bedside—is being offered by Imedex on February 4, 2017 in Chicago. Chaired by ...
(Date:1/17/2017)... ... January 17, 2017 , ... Kevin Harrington (one of the original Sharks from ... campaigns regarding the topic of Beauty and Personal Care. , Everyone ... better way to commit to these changes than beginning with personal care and beauty ...
Breaking Medicine News(10 mins):